Esperion Therapeutics Statistics
Total Valuation
ESPR has a market cap or net worth of $407.30 million. The enterprise value is $729.56 million.
| Market Cap | 407.30M |
| Enterprise Value | 729.56M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, before market open.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ESPR has 170.42 million shares outstanding. The number of shares has increased by 141.77% in one year.
| Shares Outstanding | 170.42M |
| Shares Change (YoY) | +141.77% |
| Shares Change (QoQ) | +68.56% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 69.06% |
| Float | 164.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.03 |
| PS Ratio | 1.77 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | -4.78 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.22
| Current Ratio | 2.22 |
| Quick Ratio | 1.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.40% |
| Return on Capital (ROIC) | -13.63% |
| Revenue Per Employee | $957,250 |
| Profits Per Employee | -$360,446 |
| Employee Count | 240 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 0.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.20% in the last 52 weeks. The beta is 1.02, so ESPR's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +55.20% |
| 50-Day Moving Average | 2.41 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 47.69 |
| Average Volume (20 Days) | 9,310,804 |
Short Selling Information
The latest short interest is 23.55 million, so 13.82% of the outstanding shares have been sold short.
| Short Interest | 23.55M |
| Short Previous Month | 24.89M |
| Short % of Shares Out | 13.82% |
| Short % of Float | 14.34% |
| Short Ratio (days to cover) | 2.37 |
Income Statement
In the last 12 months, ESPR had revenue of $229.74 million and -$86.51 million in losses. Loss per share was -$0.99.
| Revenue | 229.74M |
| Gross Profit | 188.05M |
| Operating Income | -34.69M |
| Pretax Income | -86.51M |
| Net Income | -86.51M |
| EBITDA | -27.81M |
| EBIT | -27.89M |
| Loss Per Share | -$0.99 |
Balance Sheet
The company has $226.61 million in cash and $548.87 million in debt, giving a net cash position of -$322.26 million or -$1.89 per share.
| Cash & Cash Equivalents | 226.61M |
| Total Debt | 548.87M |
| Net Cash | -322.26M |
| Net Cash Per Share | -$1.89 |
| Equity (Book Value) | -294.30M |
| Book Value Per Share | -1.73 |
| Working Capital | 201.09M |
Cash Flow
In the last 12 months, operating cash flow was -$27.30 million and capital expenditures -$73,000, giving a free cash flow of -$27.38 million.
| Operating Cash Flow | -27.30M |
| Capital Expenditures | -73,000 |
| Free Cash Flow | -27.38M |
| FCF Per Share | -$0.16 |
Margins
Gross margin is 81.85%, with operating and profit margins of -15.10% and -37.65%.
| Gross Margin | 81.85% |
| Operating Margin | -15.10% |
| Pretax Margin | -37.65% |
| Profit Margin | -37.65% |
| EBITDA Margin | -12.11% |
| EBIT Margin | -12.14% |
| FCF Margin | -11.92% |
Dividends & Yields
ESPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -141.77% |
| Shareholder Yield | -141.77% |
| Earnings Yield | -21.24% |
| FCF Yield | -6.72% |
Analyst Forecast
The average price target for ESPR is $8.83, which is 269.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.83 |
| Price Target Difference | 269.46% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 63.73% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ESPR has an Altman Z-Score of -4.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.2 |
| Piotroski F-Score | 3 |